Navigation Links
Universal Health Services, Inc. Reports Significant Increases In 2009 Second Quarter and Six-Month Earnings, Raises Full Year Guidance
Date:7/28/2009

09 and 2008:

At our acute care hospitals owned during both periods ("same facility basis"), inpatient admissions increased 1.5% while patient days decreased 0.8% during the second quarter of 2009, as compared to the second quarter of 2008. Net revenues at these facilities increased 2.9% during the second quarter of 2009 as compared to the comparable quarter of the prior year. At these facilities, net revenue per adjusted admission decreased 0.2% while net revenue per adjusted patient day increased 2.0% during the second quarter of 2009 as compared to the comparable quarter of the prior year. On a same facility basis, the operating margin (net revenues less salaries, wages and benefits, other operating expenses, supplies expense and provision for doubtful accounts) at our acute care hospitals increased to 16.8% during the second quarter of 2009 as compared to 14.7% during the second quarter of 2008.

We provide care to patients who meet certain financial or economic criteria without charge or at amounts substantially less than our established rates. Because we do not pursue collection of amounts determined to qualify as charity care, they are not reported in net revenues or in accounts receivable, net. Our acute care hospitals provided charity care and uninsured discounts, based on charges at established rates, amounting to $181 million and $143 million during the three-month periods ended June 30, 2009 and 2008, respectively.

Acute Care Services - Six-month periods ended June 30, 2009 and 2008:

During the six-month period ended June 30, 2009, on a same facility basis, inpatient admissions to our acute care facilities increased 0.1% while patient days decreased 1.5%, as compared to the comparable period of the prior year. Net revenues at our acute care facilities increased 1.9% during the six-month period ended June 30, 2009 as compared to the comparable period of the pr
'/>"/>

SOURCE Universal Health Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine news :

1. Universal Health Realty Income Trust Announces Dividend
2. Gentiva(R) Health Services Files Universal Shelf Registration Statement
3. Universal Health Care Coverage in the United States
4. New report: private/public insurance mix is most practical way to achieve universal coverage
5. Universal Health Services, Inc. Reports 2007 Third Quarter Earnings
6. Forum Highlights Role of Private Sector in Achieving Universal Health Coverage in Europe
7. Universal Health Services, Inc. Announces Dividend
8. Internists Diagnose Health Care System Ills, Prescribe Remedies to Achieve Universal Coverage, Better Quality, and Lower Costs
9. Internists diagnose health-care system ills, show how to achieve universal coverage
10. Universal Health Services, Inc. Announces Share Repurchase Authorization
11. Universal Health Services, Inc. Announces Dividend

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...5/PRNewswire-USNewswire/--TheBlackAIDSInstituterec...iveleadershipfor2010. ,, ThenewBoardMembersarea...policy,law,finance,governmenthealthprograms,editor...romawiderangeofpersonalbackgroundsincludingbothhet...hemselves,andrepresentingmultipleagegroups. ,, ...
(Date:11/25/2009)...ndorsements,Business,andPressJoinEfforttoEducate ...-Onceagain,theNationalBipolarFoundationandtheMedic...Safe,tilStable"program,whichisnowbeingwidelyaccept....Today,theNationalBipolarFoundationreceivedaprocla...omtheLt.GovernorofLouisianaMitchLandrieu.TheNation...
(Date:11/25/2009)... evidence of a statistically significant survival ...se estrogen receptor (ER)-positive tumors had high...118 (ER-alpha S118-P), according to a brief commun...al of the National Cancer Institute . , Approxim...moxifen. Preclinical studies have shown that ER-al...
(Date:11/25/2009)...lood pressure? This simple question has been the ...ess-related gene Modulates High Blood Pressure in ... This simple question has been the focus of intens...or the first time established a link between a nov...e to stress in mice as well as humans. The studies...
(Date:11/25/2009)...to fight rheumatoid arthritis, could help newly di...SDAY, Nov. 25 (HealthDay News) -- A drug commonly ...d arthritis now also shows some promise in helping..., The drug, rituximab (Rituxan), helped patients ...ugh the disease had destroyed some of their pancre...
Breaking Medicine News(10 mins):Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
.... 31 Biopure Corporation,(Nasdaq: BPUR ) announc...ommon stock will revert from BPURD to BPUR at the ... Outstanding warrants that trade on the OTCBB,will...re Corporation develops, manufactures and markets ...
.../PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(TS...company focused on,endocrine therapy and oncology,...d operating results before market open on Wednesda...ants may,access the live webcast via the Company,s...
...ct. 31 Allos,Therapeutics, Inc. (Nasdaq: ALTH ),...pment and commercialization of small molecule ther...ced that Paul L. Berns, President and,CEO, will pr... (Eastern) on,Tuesday, November 6, 2007. There wil...
... a record $175 million; net book-to-bill of 1.7:1,...an all-time Company high, - Third quarter operat... - Third quarter EPS of $0.25 (GAAP) and $0.48...endle (Nasdaq: KNDL ), a,leading, global full-ser...
...DVENTRX Pharmaceuticals,Inc. (Amex: ANX ), a biop...used on commercializing proprietary product candid...seases, announced today that Evan M. Levine,ADVENT...The conference takes place in New York at the Wald...
...t. 30 Medical Services,International Inc. (OTC Pi...as added 4 additional distributors in the month of...utorships these corporations will have to purchase...,a Dengue Fever Kit and only one other manufacture...
Other Medicine News:Health News:Biopure's Stock Symbol Reverts to BPUR 2Health News:Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw Conference 2Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 2Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 3Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 4Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 5Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 6Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 7Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 8Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 9Health News:ADVENTRX Pharmaceuticals to Present at the 18th Annual CIBC Healthcare Conference 2
(Date:11/25/2009)..., MOUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- Che...aldatafromtheCompany,sPROTECT-1(theProspectiveRand...fTraficet-EN(TM)(CCX282-B)inpatientswithmoderate-t...withafavorablesafetyandtolerabilityprofile.Thestud...ionofdiseaseseverityasdefinedasa70-pointdecreasein...
(Date:11/24/2009)..., PITTSBURGH,Nov.24/PRNewswire/-- ,, WHAT:Ro...arsfollowinganautoaccident,wasactuallyfullyconscio...ningAmericasegment.TheDynaVoxEyeMaxwasfeaturedinth...andotherconditionscanunlockcommunication. ,, WH...leonlineat www.dynavoxtech.com ,, WHO:Ro...
(Date:11/24/2009)..., MADISON,N.J.,Nov.24/PRNewswire-FirstCall/--Qu...eadingproviderofdiagnostictesting,informationandse...nnualPiperJaffrayHealthcareConferenceinNewYorkCity...2009at9:30a.m.EasternTime. ,, Duringtheconferen...growthtoapproximate3%,operatingincometoexceed18%of...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2LifeSpan Treadmill Awarded BEST TREADMILL by Health Magazine 52317 1LifeSpan Treadmill Awarded BEST TREADMILL by Health Magazine 52317 2Novavax Announces Appointment of John J Trizzino as Senior Vice President International and Government Alliances 13127 1Novavax Announces Appointment of John J Trizzino as Senior Vice President International and Government Alliances 13127 2Biomarkers May Predict Alzheimers 52316 1Biomarkers May Predict Alzheimers 52316 2Biomarkers May Predict Alzheimers 52316 3
...ns for treating returning vets and others exposed ... Schepens Eye Research Institute have shown for th...ause both eyes to lose a special protective abilit...ects the eye without the inflammation of the body,... delicate eye tissue. This finding, published in t...
...ExonHit Therapeutics,(Alternext: ALEHT) is pleased... lead compound in Alzheimer,s disease, is progress...l assessing EHT 0202 in patients with,Alzheimer,s ...tion of patient enrolment for the Phase IIa,repres...EHT 0202, and,provides a clear timeline for the re...
Other Medicine Technology:Laser Burn Injuries in One Eye Can Disrupt Protective Immune Privilege in Both Eyes, Study Finds 2ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 2ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 3ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 4
Naked Gold 20 nm
Naked Gold 20 nm - 50 OD
CranioFix2 Titanium Clamp System
...ate, reliable, portable, and easy-to-use pachymete... a dual-rechargeable battery system that makes cha...lution, color, touch screen controls make operatin...ent software simplifies calculating adjustments to...
Medicine Products: